Efficacy comparison of the novel water-soluble propofol prodrug HX0969w and fospropofol in mice and rats

British Journal of Anaesthesia

Volumn 111, Issue 5, 2013, Pages 825-832

  Zhou, Y ^a,b   Yang, J ^a   Liu, J ^a   Wang, Y ^a   Zhang, W S ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

anaesthetics i.v., propofol; gamma hydroxybutyrate; water soluble prodrug

Indexed keywords

FOSPROPOFOL; HX 0969W; HX0969W; PROPOFOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; DEATH; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; HYDROLYSIS; IN VIVO STUDY; LD 50; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; WAKEFULNESS;

EID: 84885913903     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet218     Document Type: Article

References (38)

1. Baker MT, Naguib M. Propofol: The challenges of formulation. Anesthesiology 2005; 103: 860-76
2. KlementW, Arndt JO. Pain on injection of propofol: Effects of concentration and diluent. Br J Anaesth 1991; 67: 281-4
3. Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia 1998; 53: 468-76
4. McKeage K, Perry CM. Propofol: A review of its use in intensive care sedation of adults. CNS Drugs 2003; 17: 235-72
5. Canbay O, Celebi N, Arun O, Karagoz AH, Saricaoglu F, Ozgen S. Efficacy of intravenous acetaminophen and lidocaine on propofol injection pain. Br J Anaesth 2008; 100: 95-8
6. Banaszczyk MG, Carlo AT, Millan V. Propofol phosphate, a watersoluble propofol prodrug: In vivo evaluation. Anesth Analg 2002; 95: 1285-92
7. SneydJR.Recent advances in intravenous anaesthesia. Br J Anaesth 2004; 93: 725-36
8. Kumpulainen H, Jarvinen T, Mannila A. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol. Eur J Pharm Sci 2008; 34: 110-7
9. Garnock-Jones KP, Scott LJ. Fospropofol. Drugs 2010; 70: 469-77
10. Zhang L, Freeman LE, Nakamura J. Formaldehyde and leukemia: Epidemiology, potential mechanisms, and implications for risk assessment. Environ Mol Mutagen 2010; 51: 181-91
11. Goldstein BD. Hematological and toxicological evaluation of formaldehyde as a potential cause of human leukemia. Hum Exp Toxicol 2011; 30: 725-35
12. HeckHD,Casanova M, Starr TB. Formaldehydetoxicity-newunderstanding. Crit Rev Toxicol 1990; 20: 397-426
13. Duong A, Steinmaus C, McHale CM, Vaughan CP, Zhang L. Reproductive and developmental toxicity of formaldehyde: A systematic review. Mutat Res 2011; 728: 118-38
14. Candiotti KA, Gan TJ, Young C. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit. Anesth Analg 2011; 113: 550-6
15. Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 2009; 89: 193-219
16. Scharf MB, Lai AA, Branigan B, Stover R, Berkowitz DB.Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 1998; 21: 507-14
17. Yin W, Wang Y, Yang J, Kang Y, Zhang WS. Determination of HX0969w in rabbit whole blood by liquid chromatography-Tandem mass spectrometry and its application in a pharmacokinetic study. Eur J Mass Spectrom (Chichester, Eng) 2011; 17: 405-13
18. Shan D, Nicolaou MG, Borchardt RT, Wang B. Prodrug strategies based on intramolecular cyclization reactions. J Pharm Sci 1997; 86: 765-7
19. StellaVJ, ZygmuntJJ, GeorgIG, Safadi MS.Water Soluble Prodrugs of Hindered Alcohols. Pub No. US7244718. Alexandria, VA: United States Patent and Trademark Office, 2007
20. AltomareC, Trapani G, Latrofa A. Highlywater-soluble derivatives of the anesthetic agent propofol: In vitro and in vivo evaluation of cyclic amino acid esters. Eur J Pharm Sci 2003; 20: 17-26
21. Kilpatrick GJ, McIntyre MS, Cox RF. CNS 7056: A novel ultra-short-Actingbenzodiazepine.Anesthesiology2007;107: 60-6
22. Glen JB, Hunter SC. Pharmacologyof an emulsion formulation of ICI 35 868. Br J Anaesth 1984; 56: 617-26
23. Adam HK, Glen JB, Hoyle PA. Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent. Br J Anaesth 1980; 52: 743-6
24. Gong DH, Weiskopf RB, Neumann MA, Laster MJ, Eger EN. In rats breathing from a nonrebreathing system, substitution of desflurane for isoflurane toward the end of anesthesia incompletely restores the time of recovery toward that of desflurane. Anesth Analg 1998; 86: 198-201
25. Fast JP, Perkins MG, Pearce RA, Mecozzi S. Fluoropolymer-based emulsions for the intravenous delivery of sevoflurane. Anesthesiology 2008; 109: 651-6
26. Zhou JX, Luo NF, Liang XM, Liu J. The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg 2006; 102: 129-34
27. Knipe JO,MosureKW.NonclinicalpharmacokineticsofBMS-292655, a water-soluble prodrug of the antifungal ravuconazole. Biopharm Drug Dispos 2008; 29: 270-9
28. Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, Gachoud JP, Suter PM. Overnight sedation with midazolam or propofol in the ICU: Effects on sleep quality, anxiety and depression. Intensive Care Med 1996; 22: 1186-90
29. Sneyd JR, Rigby-Jones AE. New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth 2010; 105: 246-54
30. Andresen H, Aydin BE,Mueller A, Iwersen-Bergmann S. An overviewof gamma-hydroxybutyric acid: Pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results. Drug Test Anal 2011; 3: 560-8
31. Raybon JJ, Boje KM. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: Effects on extracellular dopamine. J Pharmacol Exp Ther 2007; 320: 1252-60
32. Ferrara SD, Zotti S, Tedeschi L. Pharmacokinetics of gammahydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol 1992; 34: 231-5
33. Lettieri JT, Fung HL. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J Pharmacol Exp Ther 1979; 208: 7-11
34. Palatini P, Tedeschi L, Frison G. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 1993; 45: 353-6
35. Bosch OG, Quednow BB, Seifritz E, Wetter TC. Reconsidering GHB: Orphan drug or new model antidepressant? J Psychopharmacol 2012; 26: 618-28
36. Kleinschmidt S, Grundmann U, Janneck U, Kreienmeyer J, Kulosa R, Larsen R. Total intravenous anaesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery. Eur J Anaesthesiol 1997; 14: 590-9
37. Kleinschmidt S, Schellhase C, Mertzlufft F. Continuous sedation during spinal anaesthesia: Gamma-hydroxybutyrate vs. propofol. Eur J Anaesthesiol 1999; 16: 23-30
38. Vanlersberghe C, Camu F. Propofol. In: Ahonen J, Akk G, Antkowiak B, Grashoff C, eds. Handbook of Experimental Pharmacology. Berlin, Heidelberg: Springer, 2008: 227-52